Literature DB >> 31190375

miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.

Feng Liang1, Xin Fu1, Linlin Wang2.   

Abstract

Lacking of diagnostic and prognostic biomarkers is a significant reason for the poor prognosis of patients with triple-negative breast cancer (TNBC). MicroRNAs (miRNAs) have been discovered to engage in the tumorigenesis and development of TNBC. miR-5590-3p has been found to be involved in the development of gastric cancer, but its role and underlying mechanism in TNBC remain obscure. In this study, it was discovered that miR-5590-3p was downregulated in TNBC tissues and cells. Function assays confirmed that miR-5590-3p overexpression inhibited cell proliferation, migration, and epithelial-mesenchymal transition (EMT) process as well as promoted cell apoptosis in TNBC. Moreover, YY1 could bind with the promoter of miR-5590-3p and overexpression of YY1 inhibited the transcription of miR-5590-3p. It was found that YY1 acted as a downstream target gene to bind with miR-5590-3p and was negatively regulated by miR-5590-3p. Finally, it was discovered that overexpression of YY1 could partially rescue the miR-5590-3p overexpression-mediated inhibitive effect on TNBC progression. Taken together these results, it can be concluded that miR-5590-3p-YY1 feedback loop promoted the proliferation and migration of TNBC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  YY1; miR-5590-3p; triple-negative breast cancer

Mesh:

Substances:

Year:  2019        PMID: 31190375     DOI: 10.1002/jcb.29158

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

Review 1.  The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.

Authors:  Utpalendu Paul; Satarupa Banerjee
Journal:  Mol Biol Rep       Date:  2022-03-02       Impact factor: 2.742

2.  Long non-coding RNA MIR100HG promotes the migration, invasion and proliferation of triple-negative breast cancer cells by targeting the miR-5590-3p/OTX1 axis.

Authors:  Fei-Yu Chen; Zhi-Yang Zhou; Ke-Jing Zhang; Jian Pang; Shou-Man Wang
Journal:  Cancer Cell Int       Date:  2020-10-16       Impact factor: 5.722

3.  CircRNA circYY1 (hsa_circ_0101187) Modulates Cell Glycolysis and Malignancy Through Regulating YY1 Expression by Sponging miR-769-3p in Breast Cancer.

Authors:  Xiaobin Zhang; Jiehua Li; Qin Feng
Journal:  Cancer Manag Res       Date:  2021-02-09       Impact factor: 3.989

Review 4.  The Two Sides of YY1 in Cancer: A Friend and a Foe.

Authors:  Sailu Sarvagalla; Srinivasa Prasad Kolapalli; Sivakumar Vallabhapurapu
Journal:  Front Oncol       Date:  2019-11-20       Impact factor: 6.244

Review 5.  The biological implications of Yin Yang 1 in the hallmarks of cancer.

Authors:  Ian Timothy Sembiring Meliala; Rendy Hosea; Vivi Kasim; Shourong Wu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

6.  RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression.

Authors:  Yin-Ling Zhang; Jin-Ling Cao; Ye Zhang; Li Liao; Ling Deng; Shao-Ying Yang; Shu-Yuan Hu; Yan Ning; Fang-Lin Zhang; Da-Qiang Li
Journal:  Med Oncol       Date:  2022-02-01       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.